|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 271.63 USD | -3.43% |
|
-6.28% | -1.31% |
| 03-03 | Health Care Losses Limited Amid Defensive Bias - Health Care Roundup | DJ |
| 03-03 | Cigna Names Brian Evanko CEO as David Cordani Retires -- Update | DJ |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 173B | 179B | 194B | 246B | 274B | |||||
Gain (Loss) on Sale of Investment, Total (Rev) | - | - | - | - | - | |||||
Interest And Invest. Income (Rev) | 1.55B | 1.16B | 1.17B | 973M | 1.05B | |||||
Total Revenues | 174B | 181B | 195B | 247B | 275B | |||||
Cost of Goods Sold, Total | 151B | 157B | 170B | 221B | 249B | |||||
Gross Profit | 22.96B | 23.48B | 25.18B | 25.96B | 25.56B | |||||
Selling General & Admin Expenses, Total | 12.81B | 13.12B | 14.37B | 14.57B | 13.56B | |||||
Stock-Based Compensation (IS) | - | - | - | - | - | |||||
Amortization of Goodwill and Intangible Assets - (IS) | 2B | 1.88B | 1.82B | 1.7B | 1.74B | |||||
Other Operating Expenses | - | - | - | - | - | |||||
Other Operating Expenses, Total | 14.81B | 15B | 16.19B | 16.27B | 15.3B | |||||
Operating Income | 8.16B | 8.48B | 8.99B | 9.69B | 10.26B | |||||
Interest Expense, Total | -1.12B | -1.16B | -1.4B | -1.5B | -1.4B | |||||
Net Interest Expenses | -1.12B | -1.16B | -1.4B | -1.5B | -1.4B | |||||
Other Non Operating Income (Expenses) | - | - | - | 65M | -8M | |||||
EBT, Excl. Unusual Items | 7.04B | 7.32B | 7.59B | 8.26B | 8.85B | |||||
Restructuring Charges | -168M | -22M | -252M | - | -749M | |||||
Merger & Related Restructuring Charges | -169M | -135M | -45M | -275M | -327M | |||||
Gain (Loss) On Sale Of Investments | 196M | -495M | -78M | -2.74B | -24M | |||||
Gain (Loss) On Sale Of Assets | - | 1.66B | -1.5B | 24M | 13M | |||||
Legal Settlements | 27M | 28M | -201M | - | 17M | |||||
Other Unusual Items | -141M | - | - | - | - | |||||
EBT, Incl. Unusual Items | 6.78B | 8.35B | 5.51B | 5.27B | 7.78B | |||||
Income Tax Expense | 1.37B | 1.61B | 141M | 1.49B | 1.49B | |||||
Earnings From Continuing Operations | 5.42B | 6.75B | 5.37B | 3.78B | 6.29B | |||||
Net Income to Company | 5.42B | 6.75B | 5.37B | 3.78B | 6.29B | |||||
Minority Interest | -50M | -78M | -208M | -344M | -331M | |||||
Net Income - (IS) | 5.36B | 6.67B | 5.16B | 3.43B | 5.96B | |||||
Net Income to Common Incl Extra Items | 5.36B | 6.67B | 5.16B | 3.43B | 5.96B | |||||
Net Income to Common Excl. Extra Items | 5.36B | 6.67B | 5.16B | 3.43B | 5.96B | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 15.87 | 21.54 | 17.57 | 12.25 | 22.33 | |||||
Basic EPS - Continuing Operations | 15.87 | 21.54 | 17.57 | 12.25 | 22.33 | |||||
Basic Weighted Average Shares Outstanding | 338M | 310M | 294M | 280M | 267M | |||||
Net EPS - Diluted | 15.73 | 21.3 | 17.39 | 12.12 | 22.18 | |||||
Diluted EPS - Continuing Operations | 15.73 | 21.3 | 17.39 | 12.12 | 22.18 | |||||
Diluted Weighted Average Shares Outstanding | 341M | 313M | 297M | 283M | 269M | |||||
Normalized Basic EPS | 12.87 | 14.52 | 15.43 | 17.18 | 19.5 | |||||
Normalized Diluted EPS | 12.75 | 14.35 | 15.27 | 17.01 | 19.37 | |||||
Dividend Per Share | 4 | 4.48 | 4.92 | 5.6 | 6.04 | |||||
Payout Ratio | 25 | 20.76 | 28.08 | 45.63 | 27.04 | |||||
American Depositary Receipts Ratio (ADR) | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | |||||
Supplemental Items | ||||||||||
EBITDA | 9.96B | 10.34B | 10.8B | 11.45B | 12.05B | |||||
EBITA | 9.7B | 10.08B | 10.54B | 11.2B | 11.81B | |||||
EBIT | 8.16B | 8.48B | 8.99B | 9.69B | 10.26B | |||||
EBITDAR | 10.17B | 10.5B | 10.95B | - | - | |||||
Total Revenues (As Reported) | 174B | 181B | 195B | 247B | 275B | |||||
Effective Tax Rate - (Ratio) | 20.16 | 19.24 | 2.56 | 28.3 | 19.19 | |||||
Current Domestic Taxes | 1.38B | 1.87B | 1.64B | 1.34B | 976M | |||||
Current Foreign Taxes | 207M | 219M | 161M | 248M | 191M | |||||
Total Current Taxes | 1.59B | 2.09B | 1.8B | 1.59B | 1.17B | |||||
Deferred Domestic Taxes | -289M | -452M | -613M | -159M | -121M | |||||
Deferred Foreign Taxes | 69M | -28M | -1.05B | 64M | 447M | |||||
Total Deferred Taxes | -220M | -480M | -1.66B | -95M | 326M | |||||
Normalized Net Income | 4.35B | 4.49B | 4.53B | 4.82B | 5.2B | |||||
Interest on Long-Term Debt | 2M | 2M | 4M | - | - | |||||
Non-Cash Pension Expense | -55M | -43M | 52M | -13M | 2M | |||||
Supplemental Operating Expense Items | ||||||||||
Net Rental Expense, Total | 209M | 165M | 153M | - | - | |||||
Imputed Operating Lease Interest Expense | 55.17M | 46.65M | 54.46M | - | - | |||||
Imputed Operating Lease Depreciation | 154M | 118M | 98.54M | - | - | |||||
Stock-Based Comp., SG&A Exp. (Total) | 183M | 167M | 220M | 238M | 203M | |||||
Stock-Based Comp., Other (Total) | 85M | 97M | 66M | 70M | 88M | |||||
Total Stock-Based Compensation | 268M | 264M | 286M | 308M | 291M |
- Stock Market
- Equities
- CI Stock
- Financials Cigna
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















